INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹751 Cr | ₹648 Cr | ₹642 Cr | ₹444 Cr | ₹285 Cr |
What is the latest Sundry Debtors ratio of INDEGENE ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹751 Cr |
| Mar2024 | ₹648 Cr |
| Mar2023 | ₹642 Cr |
| Mar2022 | ₹444 Cr |
| Mar2021 | ₹285 Cr |
How is Sundry Debtors of INDEGENE Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹751 Cr | 15.96 | |
| Mar2024 | ₹648 Cr | 0.93 | |
| Mar2023 | ₹642 Cr | 44.62 | |
| Mar2022 | ₹444 Cr | 55.54 | |
| Mar2021 | ₹285 Cr | - | |
Compare Sundry Debtors of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹10,882.6 Cr | -5.6% | -5.9% | -12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -5.6% |
-5.9% |
-12.9% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses